Hypophysitis
ICD-10 E23.0 · ICD-11 5A61.0.2

Hypophysitis Presenting with Rapid Onset of Neurological Symptoms and Pituitary Mass Effects

A subset of patients with hypophysitis present acutely, with rapidly developing neurological symptoms driven by significant pituitary enlargement. This presentation — marked by mass effects from a swollen gland — requires a structured clinical response that goes beyond watchful waiting.

The defining feature of this presentation is the combination of rapid symptom onset and demonstrable pituitary enlargement causing neurological mass effects. Immunosuppressive therapy is a recognised approach for patients in this acute, symptomatic setting.

In cases where both medical and surgical options have been considered, a targeted radiotherapy-based intervention has demonstrated effectiveness. The complete regimen — including sequencing, selection criteria, and adjunctive considerations — is detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens
References

DOI: 10.1016/j.beem.2019.101371

Immunosuppressive therapy is utilized for patients with rapid onset of neurological symptoms and mass effects due to pituitary enlargement.

In cases that are refractory to both medical and surgical modalities, stereotactic radiotherapy has been shown to be effective.

View source ↗